Surgery Websites
Leadership »  8-Director »  Kenzo Hirose, M.D.
Kenzo Hirose, M.D.

Kenzo Hirose, M.D.

  • Associate Professor of Surgery
  • Division of Surgical Oncology
  • Director, General Surgery Residency Program

Contact Information

Phone: (415) 502-5577
Fax: (415) 502-2236
[email protected]

 
Open Popup

1995, AB, Harvard University, Biochemical Sciences
1999, MD, Harvard Medical School

  • 2000, Internship, University of California, San Francisco, General Surgery
  • 2006, Residency, University of California, San Francisco, General Surgery
  • 2007, Fellowship, Cleveland Clinic Foundation, Liver Transplantation
  • 2008, Fellowship, Cleveland Clinic Foundation, Hepatobiliary Surgery
  • American Board of Surgery
  • Hepatobiliary and Pancreas Surgery Program
  • Bile Duct Cancer (Cholangiocarcinoma)
  • Bile Duct Injuries
  • Bile Duct Strictures
  • Bridging Therapies to Downstage HCC pre-Liver Transplant
  • Choledochal Cysts
  • Gallbladder Cancer
  • Gastrointestinal Carcinoid Tumor
  • Gastrointestinal Stromal Tumor (GIST)
  • Liver Cancer (Hepatocellular Carcinoma)
  • Liver Cysts
  • Liver Metastases
  • Minimally Invasive Liver & Pancreas Surgery
  • Pancreatic Cancer
  • Pancreatic Cysts
  • Pancreatic Neuroendocrine (Islet Cell) Tumors
  • Soft Tissue Sarcomas
  • Stomach (Gastric) Cancer

Dr. Kenzo Hirose is a general surgeon specializing in benign and malignant conditions of the liver, pancreas and bile duct. He has a special interest in minimally invasive surgical techniques and conducts research in patient outcomes after surgery.   

Dr. Kenzo Hirose received his medical degree from Harvard Medical school. He did his residency in general surgery at the University of California, San Francisco and his Hepatopancreatobiliary Fellowship at the Cleveland Clinic. 

MOST RECENT PUBLICATIONS FROM A TOTAL OF 98
Data provided by UCSF Profiles, powered by CTSI
  1. Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA. ASO Visual Abstract: A Machine-Learning Approach to Predict Postoperative Pancreatic Fistula after Pancreaticoduodenectomy Using only Preoperatively Known Data. Ann Surg Oncol. 2023 Nov; 30(12):7776-7777. View in PubMed
  2. Ashraf Ganjouei A, Romero-Hernandez F, Wang JJ, Casey M, Frye W, Hoffman D, Hirose K, Nakakura E, Corvera C, Maker AV, Kirkwood KS, Alseidi A, Adam MA. A Machine Learning Approach to Predict Postoperative Pancreatic Fistula After Pancreaticoduodenectomy Using Only Preoperatively Known Data. Ann Surg Oncol. 2023 Nov; 30(12):7738-7747. View in PubMed
  3. Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA. ASO Visual Abstract: National Practice Patterns in Malignant Peritoneal Mesothelioma-Updates in Management and Survival. Ann Surg Oncol. 2023 Aug; 30(8):5131. View in PubMed
  4. Calthorpe L, Romero-Hernandez F, Casey M, Nunez M, Conroy PC, Hirose K, Kim A, Kirkwood K, Maker AV, Corvera C, Nakakura E, Alseidi A, Adam MA. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival. Ann Surg Oncol. 2023 Aug; 30(8):5119-5129. View in PubMed
  5. Tbeileh N, Timmerman L, Mattis AN, Toriguchi K, Kasai Y, Corvera C, Nakakura E, Hirose K, Donner DB, Warren RS, Karelehto E. Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data. PLoS One. 2023; 18(4):e0271354. View in PubMed
  6. View All Publications

 

Site Directory
    X